{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:45Z","timestamp":1791305925738,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.contraception.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T01:03:40Z","timestamp":1312679020000},"page":"e23-e30","source":"Crossref","is-referenced-by-count":39,"title":["Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives"],"prefix":"10.1016","volume":"84","author":[{"given":"H\u00e9l\u00e8ne","family":"Vaillant-Roussel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemlih","family":"Ouchchane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dauphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ruivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.06.008_bb0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.06.008_bb0010","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use","volume":"23","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2011.06.008_bb0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","article-title":"Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users","volume":"83","author":"Samuelsson","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.06.008_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.06.008_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.06.008_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.06.008_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","article-title":"Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis","volume":"64","author":"Hennessy","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.06.008_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.06.008_bb0045","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case\u2013control study using United States claims data","volume":"340","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.06.008_bb0050","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case\u2013control study based on UK General Practice Research Database","volume":"340","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.06.008_bb0055","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.06.008_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/107602960300900106","article-title":"Thromboembolic disease and present oral contraception","volume":"9","author":"Belicova","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.contraception.2011.06.008_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.1.5901.215","article-title":"Recurrence of venous thromboembolic disease and use of oral contraceptives","volume":"1","author":"Badaracco","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.06.008_bb0070","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2011.06.008_bb0075","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.06.008_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2011.06.008_bb0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.06.008_bb0090","series-title":"Medical eligibility criteria for contraceptive use","first-page":"176","author":"WHO Department of Reproductive Health and Research","year":"2004"},{"key":"10.1016\/j.contraception.2011.06.008_bb0095","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.06.008_bb0100","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood.V95.6.1935","article-title":"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S","volume":"95","author":"Makris","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2011.06.008_bb0105","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1055\/s-0038-1649925","article-title":"Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age","volume":"74","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2011.06.008_bb0110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2141.2001.02813.x","article-title":"A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state","volume":"113","author":"Dykes","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2011.06.008_bb0115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH09-10-0685","article-title":"Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study","volume":"104","author":"Le Gal","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2011.06.008_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.06.008_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thromres.2004.12.012","article-title":"Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment","volume":"116","author":"Santamaria","year":"2005","journal-title":"Thromb Res"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411003982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411003982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T03:02:02Z","timestamp":1592794922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411003982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0010782411003982"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.06.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}